EMG
LJPC

Ellington Management Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Ellington Management Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,500
Closed -$345K – 633
2016
Q1 		$345K Buy
+16,500
New +$294K 0.15% 201

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ellington Management Group's LJPC Position: Q2 2016 in Review

Ellington Management Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2016, closing a stake of 16,500 shares — an estimated $345K sold.

Ellington Management Group first reported a position in LJPC in Q1 2016 and held it in 1 quarter. The position peaked at $345K in Q1 2016. 73 funds tracked by Wall St. Rank hold LJPC as of Q2 2016.

  • Ellington Management Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2016 after selling out during the quarter.
  • Ellington Management Group sold 16,500 La Jolla Pharmaceutical Company shares in Q2 2016, an estimated $345K.
  • Ellington Management Group first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 1 quarter.
  • Ellington Management Group's La Jolla Pharmaceutical Company position peaked at $345K in Q1 2016.
  • 73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2016.

Based on Ellington Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.